MENU
+Compare
SMMT
Stock ticker: NASDAQ
AS OF
Mar 3, 04:59 PM (EDT)
Price
$19.13
Change
-$1.56 (-7.54%)
Capitalization
15.26B

SMMT Summit Therapeutics Forecast, Technical & Fundamental Analysis

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SMMT with price predictions
Feb 28, 2025

SMMT's Stochastic Oscillator is remaining in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SMMT moved above its 50-day moving average on February 28, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SMMT advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMMT moved out of overbought territory on January 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SMMT as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMMT turned negative on February 24, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMMT broke above its upper Bollinger Band on February 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SMMT entered a downward trend on February 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMMT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (36.364) is normal, around the industry mean (11.857). P/E Ratio (26.355) is within average values for comparable stocks, (80.120). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.578). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (242.214).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SMMT is expected to report earnings to rise 40.43% to -9 cents per share on May 08

Summit Therapeutics SMMT Stock Earnings Reports
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.01
The last earnings report on February 24 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 2.83M shares outstanding, the current market capitalization sits at 15.26B.
A.I. Advisor
published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 650 460-8308
Employees
105
Web
https://www.smmttx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNW94.181.64
+1.77%
Pinnacle West Capital Corp
SLMBP75.79-0.04
-0.05%
SLM Corp
JOUT25.98-0.92
-3.42%
Johnson Outdoors
NEO9.58-0.41
-4.10%
NeoGenomics
IGMS1.26-0.10
-7.35%
IGM Biosciences

SMMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+11.90%
BCDA - SMMT
70%
Closely correlated
-1.47%
VBIZF - SMMT
42%
Loosely correlated
N/A
XERS - SMMT
36%
Loosely correlated
+1.86%
DAWN - SMMT
32%
Poorly correlated
-3.97%
ERNA - SMMT
31%
Poorly correlated
+6.33%
More

Groups containing SMMT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+11.90%
SMMT
(2 stocks)
92%
Closely correlated
+9.17%